FIELD: medicine.
SUBSTANCE: invention relates to compounds selected from a group consisting of compounds 101, 102, 103, 104, etc. that relate to macrocyclic antibiotics of a wide range of actions and that can be used for the treatment of various bacterial infections. The invention also relates to a pharmaceutical composition and a method for the treatment of a bacterial infection using the specified compounds.
EFFECT: obtaining compounds for the treatment of bacterial infections.
,
,
,
4 cl, 1 dwg, 2 tbl, 432 ex
Title | Year | Author | Number |
---|---|---|---|
MACROCYCLIC WIDE-RANGE ANTIBIOTICS | 2018 |
|
RU2779477C2 |
MACROCYCLIC ANTIBIOTICS OF WIDE SPECTRUM OF ACTION | 2016 |
|
RU2761476C2 |
BICYCLIC AGONISTS OF THE INTERFERON GENE STIMULATOR STING | 2020 |
|
RU2800072C1 |
NEW ACTIVATORS OF SOLUBLE GUANYLATE CYCLASE AND PHOSPHODIESTERASE INHIBITORS WITH DUAL ACTION MECHANISM AND THEIR APPLICATION | 2018 |
|
RU2758373C2 |
CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS CONTAINING THEM | 2018 |
|
RU2795146C2 |
INHIBITORS OF CDK | 2011 |
|
RU2621674C2 |
PYRAZOLE-BASED MAGL INHIBITORS | 2018 |
|
RU2789157C2 |
ANALOGUES OF 4H-PYRAZOLO[1,5-A]BENZIMIDAZOLE COMPOUNDS AS PARP INHIBITORS | 2015 |
|
RU2672722C2 |
MEK INHIBITORS AND THEIR THERAPEUTIC USE | 2021 |
|
RU2812929C1 |
PREPARATION AND USE OF KINASE INHIBITOR | 2016 |
|
RU2691401C2 |
Authors
Dates
2022-03-15—Published
2016-11-21—Filed